Spiolto Respimat Innöndunarlausn 2,5/2,5 míkróg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

spiolto respimat innöndunarlausn 2,5/2,5 míkróg

boehringer ingelheim international gmbh* - tiotropii bromidum inn; olodaterolum hýdróklóríð - innöndunarlausn - 2,5/2,5 míkróg

Topimax Hart hylki 15 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

topimax hart hylki 15 mg

janssen-cilag ab - topiramatum inn - hart hylki - 15 mg

Prometax 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

prometax

novartis europharm limited - rivastigmin - alzheimer disease; parkinson disease; dementia - psychoanaleptics, - einkennum meðferð vægt til nokkuð alvarlega alzheimer heilabilun. einkennum meðferð vægt til nokkuð alvarlega heilabilun í sjúklinga með sjálfvakin parkinsonsveiki.

Naproxen Viatris (Naproxen Mylan) Tafla 500 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

naproxen viatris (naproxen mylan) tafla 500 mg

viatris limited - naproxenum inn - tafla - 500 mg

Seloken ZOC Forðatafla 23,75 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

seloken zoc forðatafla 23,75 mg

recordati ireland limited* - metoprololum súkkínat - forðatafla - 23,75 mg

Myleran Filmuhúðuð tafla 2 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

myleran filmuhúðuð tafla 2 mg

aspen pharma trading limited - busulfanum inn - filmuhúðuð tafla - 2 mg

Tamoxifen Mylan Tafla 20 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

tamoxifen mylan tafla 20 mg

viatris limited - tamoxifenum cítrat - tafla - 20 mg

Eucreas 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).

Zomarist 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - lyf notuð við sykursýki - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.